Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-79
SponsorKorea University Guro Hospital
About this trial
The objective of this prospective, non-randomized clinical trial is to evaluate the effectiveness of a pharmacist-led Opioid Stewardship Program (OSP) in outpatient adults with chronic non-cancer pain. This study compared OSP implementation with a historical control to determine whether it reduces the incidence of high-risk opioid prescribing and improves patients' awareness, knowledge, and attitudes about opioid use.
Eligibility criteria
Qualifiers
Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine & Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal, sublingual, or buccal formulations containing oxycodone, fentanyl, tapentadol, hydrocodone, or morphine) due to chronic non-cancer pain during the study evaluation period (from IRB approval date to September 30, 2025)
Adults aged ≥19 years and <80 years
Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose
Disqualifiers
Patients with active cancer
Patients diagnosed with sickle cell disease
Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE END OF LIFE'
Pregnant patients
Trial design
Treatments tested in this trial
- Opioid Stewardship Program
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Korea University Guro Hospital
Lead sponsor
Korea Hospital Pharmaceutical Education & Research Center
Collaborator
Korea University
Collaborator
Source ClinicalTrials.gov